• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞内乙型肝炎表面抗原(HBsAg)、乙型肝炎核心抗原(HBcAg)及IgG对炎症性肝病分类的诊断意义。(对HBsAg阳性和阴性患者的研究)

The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HBsAg), hepatitis-B-core-antigen (HBcAg) and IgG for the classification of inflammatory liver diseases. (Studies on HBsAg-positive and -negative patients).

作者信息

Arnold W, Meyer zum Büschenfelde K H, Hess G, Knolle J

出版信息

Klin Wochenschr. 1975 Nov 15;53(22):1069-74. doi: 10.1007/BF01614383.

DOI:10.1007/BF01614383
PMID:1226039
Abstract

Liver biopsies of patients with inflammatory liver diseases and clinically healthy HBsAg-carriers were examined for presence of intracellular HBsAg, HBcAg and IgG by direct immunofluorescence. The studies revealed the following results: 1. In most cases healthy HBsAg-carriers had HBsAg in the cytoplasm, but they did never show HBcAg in the nuclei of hepatocytes. 2. In the early phase some patients with HBsAg-positive acute hepatitis had HBcAg and/or HBsAg in their hepatocytes. In a normal course with complete recovery the immunoelimination may clear either phenomenon at variable stages of the disease. 3. Cases one year after complete recovery of acute virus B-hepatitis had no HB-components in their liver tissue. 2 cases without immunoelimination of HBsAg developed chronic active hepatitis within one year and had HBcAg in their liver cell nuclei. 4. Patients with HBsAg-positive CAH and highly inflammatory activity had HBcAg in the nuclei and a low percentage of cells with HBsAg in the cytoplasm of hepatocytes. HBsAg-negative cases with CAH never had HB-components in their tissue. 5. Patients with HBsAg-positive and -negative CAH in complete remission never had HBcAg and HBsAg in their hepatocytes. 6. Most cases with HBsAg-positive acute hepatitis and chronic active hepatitis positive for HBcAg had also IgG in the same liver cell nuclei. The coincidence of this finding gives strong evidence for the presence of anti-HBc in these liver cell nuclei. The importance of this finding for the course of the disease is unknown.

摘要

通过直接免疫荧光法检查了炎症性肝病患者和临床健康的HBsAg携带者的肝活检组织中细胞内HBsAg、HBcAg和IgG的存在情况。研究结果如下:1. 在大多数情况下,健康的HBsAg携带者肝细胞胞质中有HBsAg,但肝细胞细胞核中从未出现过HBcAg。2. 在早期,一些HBsAg阳性急性肝炎患者的肝细胞中有HBcAg和/或HBsAg。在病情完全恢复的正常病程中,免疫清除可能在疾病的不同阶段清除这两种现象。3. 急性乙型肝炎完全恢复一年后的病例,其肝组织中没有HB成分。2例未清除HBsAg的患者在一年内发展为慢性活动性肝炎,其肝细胞细胞核中有HBcAg。4. HBsAg阳性且炎症活动度高的慢性活动性肝炎患者,其细胞核中有HBcAg,肝细胞胞质中含有HBsAg的细胞比例较低。HBsAg阴性的慢性活动性肝炎病例,其组织中从未有过HB成分。5. 处于完全缓解期的HBsAg阳性和阴性慢性活动性肝炎患者,其肝细胞中从未有过HBcAg和HBsAg。6. 大多数HBsAg阳性急性肝炎和HBcAg阳性慢性活动性肝炎病例,其同一肝细胞细胞核中也有IgG。这一发现的巧合有力地证明了这些肝细胞细胞核中存在抗HBc。这一发现对疾病进程的重要性尚不清楚。

相似文献

1
The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HBsAg), hepatitis-B-core-antigen (HBcAg) and IgG for the classification of inflammatory liver diseases. (Studies on HBsAg-positive and -negative patients).肝细胞内乙型肝炎表面抗原(HBsAg)、乙型肝炎核心抗原(HBcAg)及IgG对炎症性肝病分类的诊断意义。(对HBsAg阳性和阴性患者的研究)
Klin Wochenschr. 1975 Nov 15;53(22):1069-74. doi: 10.1007/BF01614383.
2
Nuclear fluorescence of liver cells for IgG in viral hepatitis B: significance and relation to hepatitis B-core and anti-hepatitis B-core formation.乙型病毒性肝炎中肝细胞IgG的核荧光:意义及其与乙肝核心抗体和抗乙肝核心抗体形成的关系
Klin Wochenschr. 1977 Apr 1;55(7):329-36. doi: 10.1007/BF01488111.
3
Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients.乙肝患者肝脏中乙肝表面抗原和乙肝核心抗原的差异分布。
Gastroenterology. 1976 Sep;71(3):462-9.
4
e System and intrahepatocelullar HBcAG and HBsAG in HBsAG positive patients with liver diseases and healthy carriers.乙肝表面抗原阳性的肝病患者和健康携带者中的乙肝核心抗原和乙肝表面抗原系统及肝内情况 。 你提供的原文似乎不太完整准确,可能会影响理解,如果有更准确完整的原文可随时告诉我。
Scand J Gastroenterol. 1977;12(3):325-30. doi: 10.3109/00365527709180935.
5
[Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].[急性肝炎患者以及伴有或不伴有肝脏疾病的HBsAg携带者对HBsAg、HBcAg和e抗原的免疫反应]
Z Gastroenterol. 1976 May;14(3):365-77.
6
Expression of HBsAg and HBcAg in liver tissue: correlation with disease activity.肝组织中乙肝表面抗原(HBsAg)和乙肝核心抗原(HBcAg)的表达:与疾病活动的相关性
Histol Histopathol. 1992 Jul;7(3):493-9.
7
Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection.慢性乙型肝炎病毒感染患者分离的肝细胞中乙型肝炎病毒抗原表达与自体淋巴细胞细胞毒性之间的关系。
Hepatology. 1984 Jan-Feb;4(1):63-8. doi: 10.1002/hep.1840040111.
8
[Classification and infectiousness of chronic hepatitis B, defined by the Dane particle in the blood and virus components in the liver].[根据血液中的 Dane 颗粒和肝脏中的病毒成分对慢性乙型肝炎进行的分类及传染性]
Schweiz Med Wochenschr. 1976 Jun 12;106(24):812-24.
9
Immunohistochemical techniques for the demonstration of viral antigens in liver tissue.用于在肝组织中显示病毒抗原的免疫组织化学技术。
Ric Clin Lab. 1988 Apr-Sep;18(2-3):223-31. doi: 10.1007/BF02918885.
10
Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases.健康乙肝表面抗原携带者及炎症性肝病患者的抗乙肝核心抗体、乙肝e抗原和DNA聚合酶活性
Klin Wochenschr. 1978 Mar 15;56(6):297-303. doi: 10.1007/BF01489176.

引用本文的文献

1
Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with type B hepatitis.采用放射免疫分析法(RIA)对慢性乙肝表面抗原(HBsAg)携带者及B型肝炎患者血清中的e抗原(HBeAg)和e抗体(抗-HBe)进行定量分析。
Klin Wochenschr. 1981 Jun 15;59(12):679-83. doi: 10.1007/BF02593860.
2
IgM antibody to hepatitis B core antigen (anti-HBc IgM) in "healthy" HBsAg carriers: a longitudinal study of 75 cases.“健康”乙肝表面抗原携带者的乙肝核心抗原 IgM 抗体(抗-HBc IgM):75 例患者的纵向研究
Klin Wochenschr. 1981 Jun 15;59(12):675-8. doi: 10.1007/BF02593859.
3
The immunopathology of acute type B hepatitis.

本文引用的文献

1
Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis.急性病毒性肝炎患者中澳大利亚抗原持续存在的发生率及意义:慢性肝炎的发展
N Engl J Med. 1971 Nov 18;285(21):1157-60. doi: 10.1056/NEJM197111182852101.
2
Virus-like particles within hepatocytes of Australia antigen carriers.澳大利亚抗原携带者肝细胞内的病毒样颗粒。
Am J Dis Child. 1972 Apr;123(4):309-11. doi: 10.1001/archpedi.1972.02110100041014.
3
Cell-mediated immune response to hepatitis B antigen in patients with liver disease.
急性乙型肝炎的免疫病理学
Springer Semin Immunopathol. 1981 Apr;3(4):421-38. doi: 10.1007/BF01951491.
4
Chronic viral hepatitis B in childhood. II. Immunological studies in serum and liver tissue and family studies.儿童慢性乙型病毒性肝炎。II. 血清和肝组织的免疫学研究及家族研究。
Eur J Pediatr. 1981 Mar;136(1):57-62. doi: 10.1007/BF00441712.
5
Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus.土拨鼠感染土拨鼠肝炎病毒后的核心抗原和抗体
J Virol. 1984 Oct;52(1):70-6. doi: 10.1128/JVI.52.1.70-76.1984.
6
Quantitation of hepatitis B virus (HBV) core antigen in serum in the presence of antibodies to HBV core antigen: comparison with assays of serum HBV DNA, DNA polymerase, and HBV e antigen.在存在乙肝病毒核心抗原抗体的情况下对血清中乙肝病毒(HBV)核心抗原进行定量:与血清HBV DNA、DNA聚合酶及乙肝病毒e抗原检测方法的比较
J Clin Microbiol. 1985 Apr;21(4):593-8. doi: 10.1128/jcm.21.4.593-598.1985.
7
Hepatitis B virus replication in steroid-treated severe HBsAg-positive chronic active hepatitis.类固醇治疗的严重乙肝表面抗原阳性慢性活动性肝炎中的乙肝病毒复制
Dig Dis Sci. 1985 Feb;30(2):97-103. doi: 10.1007/BF01308192.
8
[The characterization of clinically healthy hepatitis-b-surface-antigen (HBsAg)-carriers. Clinical, biochemical, histiological and immunological investigations in 129 case of a prospective study (author's transl)].[临床健康的乙型肝炎表面抗原(HBsAg)携带者的特征。一项前瞻性研究中129例病例的临床、生化、组织学和免疫学调查(作者译)]
Klin Wochenschr. 1976 Jun 15;54(12):567-78. doi: 10.1007/BF01619572.
9
Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases.健康乙肝表面抗原携带者及炎症性肝病患者的抗乙肝核心抗体、乙肝e抗原和DNA聚合酶活性
Klin Wochenschr. 1978 Mar 15;56(6):297-303. doi: 10.1007/BF01489176.
10
[Spread of hepatitis B virus infection among family contacts of asymptomatic HBsAg carriers (author's transl)].无症状乙肝表面抗原携带者家庭接触者中乙肝病毒感染的传播(作者译)
Klin Wochenschr. 1979 Dec 3;57(23):1287-94. doi: 10.1007/BF01492984.
肝病患者对乙肝抗原的细胞介导免疫反应。
Am J Dig Dis. 1974 Jul;19(7):637-43. doi: 10.1007/BF01073019.
4
Duality of hepatitis B antigen and its antibody. I. Immunofluorescence studies.乙肝抗原与其抗体的双重性。I. 免疫荧光研究。
J Infect Dis. 1973 Apr;127(4):424-8. doi: 10.1093/infdis/127.4.424.
5
Hepatitis B antigen: nature and distribution of cytoplasmic antigen in hepatocytes of carriers.
Proc Soc Exp Biol Med. 1974 Mar;145(3):863-7. doi: 10.3181/00379727-145-37912.
6
Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers.携带者“毛玻璃样”肝细胞中的细胞质乙肝抗原。
Arch Pathol. 1973 Nov;96(5):327-30.
7
The localization of the Australia antigen in the liver by immunofluorescence.通过免疫荧光法对澳大利亚抗原在肝脏中的定位。
J Clin Pathol. 1972 Dec;25(12):1071-4. doi: 10.1136/jcp.25.12.1071.
8
A study of the relationship of virus-like particles and Australia antigen in liver.肝脏中病毒样颗粒与澳大利亚抗原关系的研究
Hum Pathol. 1974 Mar;5(2):209-22. doi: 10.1016/s0046-8177(74)80067-5.
9
Virus-like particles in the cytoplasm of the livers of Australia antigen carriers.澳大利亚抗原携带者肝脏细胞质中的病毒样颗粒。
Am J Dis Child. 1972 Apr;123(4):313-4. doi: 10.1001/archpedi.1972.02110100045016.
10
Investigations of liver biopsies for Australia antigen by immunofluorescent technique.采用免疫荧光技术对澳大利亚抗原进行肝活检研究。
Clin Exp Immunol. 1971 Dec;9(6):699-705.